VITROS® B•R•A•H•M•S PCT (Procalcitonin)

The power of B•R•A•H•M•S with the difference that only VITROS® can deliver

Be one of the first to run this assay

B•R•A•H•M•S PCT is the best biomarker for early bacterial Sepsis

Sepsis is a life threatening condition where the body overreacts to an infection. It affects more than 30 million people with 6 million deaths around the world each year. Identifying and treating the condition as early as possible has been shown to increase the likelihood of survival.

Confidence in decisions for Clinicians

  • Early diagnosis of severe bacterial infections and sepsis 1,2

  • Therapeutic guidance for starting and safely stopping antibiotic treatment3,4

  • Excellent analytical correlation and clinical concordance to B•R•A•H•M•S method

1. Harbarth S, Holeckova K, Froidevaux C et al. Diagnostic value of procalcitonin, interleukin-6, and interlukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.

2. Brunkhorst FM, Wegscheider K, Forycki ZF, et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med. 26:148-152; 2000.

3. Branche A, Neeser O, Müller B et al. Procalcitonin to guide antibiotic decision making. Curr Opin Infect Dis. 2019;32(2):130-135.

4. Schuetz P, Bolliger R, Merker M, et al. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials. Expert Rev Anti Infect Ther.2018;16(7):555-564.

Trust in Results for Laboratories


Fulfill more requests from difficult draws with small sample volume 30μL


Trust your results through a quantification of endogenous interferences hemolysis, icterus and turbidity


Maximize efficiency with long calibration intervals 56 Days

Request more information about VITROS B•R•A•H•M•S PCT Assay

All fields (marked with a star) are required.

By completing and submitting the information below, you are requesting for Ortho Clinical Diagnostics to contact you. By clicking "Submit", you agree that your information will be governed by our Privacy Notice.